- Filed
- Sep 4, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2024 · Jun 30, 2024 | 82.5M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 81.17M sh |
| Long Term Debt | Q2 2024 · Jun 30, 2024 | $9.16M |
| Short Term Debt | Q2 2024 · Jun 30, 2024 | $35.91M |
| Short Term Debt | Q2 2024 · Dec 31, 2023 | $36.13M |
| Short Term Debt | Q2 2024 · Jun 30, 2023 | $34.86M |
| Stockholders Equity | Q2 2024 · Jun 30, 2024 | $112.3M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $107.95M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $122.15M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $136.38M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $146.18M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $153.53M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $159.2M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $149.11M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $263.78M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $265.84M |
| Eps Diluted | Q2 2024 · Jun 30, 2024 | $0.06 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.08 |
| Eps Basic | Q2 2024 · Jun 30, 2024 | $0.06 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.08 |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $26.73M |
| Capex | Q2 2024 · Jun 30, 2023 | $5.23M |
| Operating Cash Flow restated | Q2 2024 · Jun 30, 2023 | $9.78M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $10.98M |
| Net Income | Q2 2024 · Jun 30, 2023 | $6.44M |
| Operating Income | Q2 2024 · Jun 30, 2023 | $8.46M |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $22.78M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $162.2M |
| Revenue | Q2 2024 · Jun 30, 2023 | $184.97M |